Metlife Inc (MET)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Total Investments | 472,178,000 | 463,702,000 | 456,691,000 | 450,409,000 | 441,364,000 |
| Cash & Cash Equivalents | 22,032,000 | 20,233,000 | 22,178,000 | 21,326,000 | 20,068,000 |
| Equity Investments | 858,000 | 788,000 | 790,000 | 747,000 | 712,000 |
| Accrued Investment Income | 3,719,000 | 3,791,000 | 3,532,000 | 3,557,000 | 3,489,000 |
| Premiums Receivable | 49,059,000 | 40,329,000 | 31,503,000 | 31,251,000 | 29,761,000 |
| Deferred Policy Acquisition Costs | 21,107,000 | 21,175,000 | 20,993,000 | 20,162,000 | 19,627,000 |
| Deferred Assets | 2,585,000 | 2,719,000 | 2,925,000 | 2,524,000 | 2,994,000 |
| Intangibles | 9,613,000 | 9,095,000 | 9,142,000 | 9,036,000 | 8,901,000 |
| Separate Account Assets | 151,933,000 | 146,344,000 | 143,175,000 | 138,143,000 | 139,504,000 |
| Other assets | 713,521,000 | 690,398,000 | 671,150,000 | 657,954,000 | 648,488,000 |
| Total Assets | $745,166,000 | $719,726,000 | $702,470,000 | $688,316,000 | $677,457,000 |
| Liabilities | |||||
| Future Policy Benefits | 231,687,000 | 222,484,000 | 221,940,000 | 220,390,000 | 215,511,000 |
| Policyholder Funds | 236,857,000 | 235,312,000 | 232,433,000 | 225,623,000 | 221,445,000 |
| Long Term Debt | 14,819,000 | 15,698,000 | 15,812,000 | 15,158,000 | 15,562,000 |
| Separate Account Liabilities | 151,933,000 | 146,344,000 | 143,175,000 | 138,143,000 | 139,504,000 |
| Other liabilities | 701,667,000 | 674,837,000 | 658,731,000 | 645,403,000 | 634,192,000 |
| Total Liabilities | $716,486,000 | $690,535,000 | $674,543,000 | $660,561,000 | $649,754,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 652,054 | 658,892 | 665,026 | 671,298 | 681,228 |
| Common Shares | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 |
| Additional Paid Capital | 32,858,000 | 32,855,000 | 33,822,000 | 33,820,000 | 33,791,000 |
| Retained earnings | 44,290,000 | 43,887,000 | 43,447,000 | 43,131,000 | 42,626,000 |
| Treasury Shares | 30,678,000 | 30,244,000 | 29,737,000 | 29,222,000 | 27,798,000 |
| Other shareholders' equity | -17,802,000 | -17,319,000 | -19,617,000 | -19,986,000 | -20,928,000 |
| TOTAL | $28,680,000 | $29,191,000 | $27,927,000 | $27,755,000 | $27,703,000 |
| Total Liabilities And Equity | $745,166,000 | $719,726,000 | $702,470,000 | $688,316,000 | $677,457,000 |